OTCMKTS:INIS International Isotopes (INIS) Stock Price, News & Analysis $0.05 0.00 (0.00%) As of 10/9/2026 10:30 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and TrendsSEC Filings About International Isotopes Stock (OTCMKTS:INIS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get International Isotopes alerts:Sign Up Key Stats Today's Range$0.05▼$0.0550-Day Range$0.05▼$0.0752-Week Range$0.05▼$0.11Volume35,000 shsAverage Volume24,734 shsMarket Capitalization$29.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview International Isotopes Inc. is a nuclear medicine and isotope-production company headquartered in Idaho Falls, Idaho. The company focuses on producing, processing and distributing radioisotopes and radiopharmaceutical products used in medical imaging, cancer treatment, industrial applications and scientific research. Its activities have included the development and supply of medical isotopes such as fluorine-18, iodine-131, cobalt-57 and germanium-68, as well as related radiopharmaceutical and isotope products. International Isotopes has also pursued technologies for isotope processing and the production of enriched isotopes for healthcare, industrial and research customers. The company has historically served customers in the United States and other international markets through isotope distribution and related nuclear products. Its operations and product offerings have evolved over time, and publicly available information about its current business activities and leadership is limited.AI Generated. May Contain Errors. Read More International Isotopes Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks25th Percentile Overall ScoreINIS MarketRank™: International Isotopes scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for International Isotopes. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioInternational Isotopes has a P/B Ratio of 5.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of International Isotopes has been sold short.Short Interest Ratio / Days to CoverInternational Isotopes has a short interest ratio ("days to cover") of 0.07, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in International Isotopes has recently decreased by 84.47%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInternational Isotopes does not currently pay a dividend.Dividend GrowthInternational Isotopes does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment1.15 News SentimentInternational Isotopes has a news sentiment score of 1.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 2 news articles for International Isotopes this week, compared to 0 articles on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, International Isotopes insiders have not sold or bought any company stock.Percentage Held by Insiders18.73% of the stock of International Isotopes is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsInternational Isotopes has minimal institutional ownership at this time.Read more about International Isotopes' insider trading history. Receive INIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Isotopes and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INIS Stock News HeadlinesInternational Isotopes (OTCMKTS:INIS) Share Price Crosses Below 200-Day Moving Average - Should You Sell?October 7 at 3:01 AM | americanbankingnews.comRadnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO NuclearOctober 1, 2026 | prnewswire.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.October 10 at 1:00 AM | Porter & Company (Ad)International Isotopes Inc.: Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory ...August 13, 2026 | finanznachrichten.deRadnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset AcquisitionAugust 13, 2026 | prnewswire.comRadnostix Enhances Capital Flexibility with Note AmendmentsJuly 4, 2026 | theglobeandmail.comRadnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device PortfolioJuly 2, 2026 | prnewswire.comRadnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational ShutdownMay 21, 2026 | prnewswire.comSee More Headlines INIS Stock Analysis - Frequently Asked Questions How have INIS shares performed this year? International Isotopes' stock was trading at $0.0613 at the start of the year. Since then, INIS shares have decreased by 11.9% and is now trading at $0.0540. How were International Isotopes' earnings last quarter? International Isotopes Inc. (OTCMKTS:INIS) announced its quarterly earnings data on Monday, April, 2nd. The technology company reported $0.00 earnings per share for the quarter. The technology company had revenue of $1.90 million for the quarter. International Isotopes had a negative net margin of 25.52% and a negative trailing twelve-month return on equity of 92.97%. How do I buy shares of International Isotopes? Shares of INIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of International Isotopes own? Based on aggregate information from My MarketBeat watchlists, some other companies that International Isotopes investors own include Prospect Capital (PSEC), Calumet (CLMT), Two Harbors Investments (TWO), NovoCure (NVCR) and Company Calendar Last Earnings4/02/2018Today10/10/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorTechnology Industry Electronic Equipment, Instruments & Components Sub-IndustryElectronic Equipment & Instruments Current SymbolOTCMKTS:INIS CIK1038277 Webwww.intisoid.com Phone(208) 524-5300Fax208-524-1411Employees30Year Founded1995Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$910 thousand Net Margins-25.52% Pretax Margin-25.51% Return on Equity-92.97% Return on Assets-16.49% Debt Debt-to-Equity Ratio1.17 Current Ratio0.84 Quick Ratio0.69 Sales & Book Value Annual Sales$13.07 million Price / Sales2.24 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book5.40Miscellaneous Outstanding Shares542,150,000Free Float440,602,000Market Cap$29.28 million OptionableNot Optionable Beta1.31 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:INIS) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTech expert smashes iPhone with golf clubTwenty years ago, Josh Baylin told Congress the iPhone was coming, three years before it launched. A $1,500 be...Stansberry Research | SponsoredElon’s Hiding a Potential $20 Trillion Monster Inside TeslaElon Musk says there is a product inside Tesla's factories he calls the biggest ever made, ten times bigger th...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Isotopes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share International Isotopes With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
